http://medicalxpress.com/ en-us Medical Xpress internet news portal provides the latest news on Health and Medicine. (HealthDay)—For patients with vitreous hemorrhage from proliferative diabetic retinopathy (PDR), the probability of vitrectomy within 16 weeks after intravitreal injections of ranibizumab or saline is lower than expected, with little difference seen between the two treatments, according to a study published online Jan. 31 in JAMA Ophthalmology. http://medicalxpress.com/news/2013-02-ranibizumab-saline-vitreous-hemorrhage.html Ophthalmology Fri, 01 Feb 2013 11:00:01 EST news278938080 Millions of people with "wet" macular degeneration are prescribed a class of medication known as anti-VEGF drugs. But now scientists at The Scripps Research Institute (TSRI) have found that a drastic reduction of VEGF activity may do more harm than good. http://medicalxpress.com/news/2012-10-caution-drugs-macular-degeneration.html Cancer Thu, 25 Oct 2012 09:12:46 EST news270375134 (HealthDay)—Long-term aggressive treatment of patients with macular edema with ranibizumab during a third year correlates with reduced mean foveal thickness (FTH) and improved best-corrected visual acuity (BCVA), according to research published online Oct. 8 in the Archives of Ophthalmology. http://medicalxpress.com/news/2012-10-long-term-ranibizumab-beneficial-macular-edema.html Ophthalmology Thu, 11 Oct 2012 18:30:01 EST news269194573 At two years, Avastin (bevacizumab) and Lucentis (ranibizumab injection), two widely used drugs to treat age-related macular degeneration (AMD), improve vision when administered monthly or on an as needed basis, although greater improvements in vision were seen with monthly administration for this common, debilitating eye disease, according to researchers supported by the National Institutes of Health. http://medicalxpress.com/news/2012-04-avastin-lucentis-equivalent-age-related-macular.html Ophthalmology Mon, 30 Apr 2012 14:40:01 EST news255013861 People who are losing their eyesight through aged-related macular degeneration (AMD) may soon be able to find out if a commonly used drug can help save their vision. http://medicalxpress.com/news/2012-03-sight.html Ophthalmology Thu, 15 Mar 2012 09:38:17 EST news251023071 Two major drug trials conclude there was little risk from a drug aimed at age-related macular degeneration. Yet a Mayo Clinic ophthalmologist began to note something concerning in some of her patients: an increase in pressure inside the eye. It led to a retrospective study and findings that will be presented at the American Academy of Ophthalmology in Orlando. http://medicalxpress.com/news/2011-10-mayo-clinic-side-effect-macular.html Diseases, Conditions, Syndromes Mon, 24 Oct 2011 09:40:56 EST news238668041 A computer modeling study suggests that administering the drug ranibizumab is associated with reducing the magnitude of legal blindness and visual impairment caused by age-related macular degeneration in non-Hispanic white individuals, according to a report in the June issue of Archives of Ophthalmology. http://medicalxpress.com/news/2011-06-potential-ranibizumab-age-related-macular-degeneration.html Ophthalmology Mon, 13 Jun 2011 16:02:30 EST news227199734